ActiOn PACT UK (ActivOnline: Physical Activity in Cystic Fibrosis)

Details

Therapeutic approach
Behavioural
Trial status
Closed with results Participating Centres
Trials Tracker ID
TT006286
Last updated
22/06/2021

Full title

A randomised controlled trial of a novel web-based intervention to promote physical activity participation in people with cystic fibrosis

Study details

Exercise and physical activity are beneficial for people with cystic fibrosis (CF), as it helps with airway clearance and quality of life. This project will establish if an internet-based physical activity logging programme (called ‘ActivOnline’) increases physical activity participation in people with CF aged 12-35 years.



This programme has been trialed in a small group of adults with CF, and we now want to see if this is effective in a younger population, as well as a wider group of young adults.



The investigations for this study includes three separate rounds of some questionnaires, wearing a physical activity monitor for a week, and spirometry, all done in your own home.



The study is open to anyone receiving their care in England (you do not need to be receiving your care, or living in Exeter to take part).



The total time commitment for participation is six months (three of which may be using the intervention).


Study results

The purpose of this study was to evaluate whether ActivOnline, a physical activity intervention delivered online, was effective at increasing physical activity in adolescents and adults (ages 12 – 35) with CF. 

This study was forced to pause following the onset of the COVID-19 pandemic in 2020. The trial plan was modified to include online recruitment and remote assessment of outcome measures, instead of doing everything in hospital like most trials. The investigators made repeated attempts to bolster recruitment, including using the Cystic Fibrosis Trust’s Trials Tracker, social media campaigns, and communication with clinicians and academics.

However, despite these changes, the trial failed to recruit participants (zero total enrolment) and was terminated in September 2021. The study leads thought that the lack of enrolment in the trial was due to the trial coinciding with the licensing of modulators, like Kaftrio, in the summer of 2020 and the pandemic leading to an increase in online exercise activity.

The funders approved a subsequent online survey that examined the effects of the pandemic on physical activity among adolescents and adults with CF. This survey received 156 responses from the CF community and the data showed that 37% of respondents thought that exercise was more important after the pandemic (compared to beforehand) and 13% considered it to be less important.


Phase
Not applicable
Length of participation
6 Months
Recruitment target
110

Who can take part?

Age range
12-35 years
Including people

Aged 12-35 years (inclusive)

Access to the internet (e.g. computer, smart phone)

Living, and receiving care, in England

Excluding people

Any co-morbidity that may limit participation in physical activity (e.g. heart problem, joints problems)

Pregnancy

Previous lung transplantation

Remote participation
Remote participation is possible for this trial
Get in touch

CF centres running this trial

Closed

Royal Devon & Exeter Hospital

CTAP centre
NHS Trust
The Royal Devon & Exeter NHS Foundation Trust
Address
Barrack Road
EX2 5DW
Trial Coordinators
Sophie Whiteley